Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542723 | SCV000654433 | likely benign | Epilepsy, familial adult myoclonic, 5 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000542723 | SCV000782682 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2017-06-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000542723 | SCV000896224 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000542723 | SCV003831077 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925694 | SCV004746643 | likely benign | CNTN2-related disorder | 2023-04-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |